<DOC>
	<DOCNO>NCT00773487</DOCNO>
	<brief_summary>The primary objective study elucidate effect Diesel particles allergic inflammation airway asthmatic patient .</brief_summary>
	<brief_title>Influence Diesel Exhaust Particles ( DEP ) With Without Organic Compounds Allergic Inflammation Asthmatic Subjects</brief_title>
	<detailed_description>A first bronchoscopy perform baseline bronchoalveolar lavage ( BAL ) epithelial brush follow segmental instillation allergen ( grass mix house dust mite ) alone , combination Diesel particle , combination Diesel particles without organic compound saline control four different lung segment . After 24 hour , second bronchoscopy , BAL sample collect challenged segment order obtain cell lavage fluid cell biological immunological analysis .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Able willing give write informed consent Physician diagnosis mild intermittent mild persistent asthma accord GINA guideline { Bateman , 2008 34 /id } Age 1855 year Nonsmokers history le 1 packyear nonsmoker least last five year FEV1 &gt; = 80 % predict , FEV1/FVC &gt; = 70 % Positive skin prick test grass mix D. pteronyssinus within 12 month prior screen visit Positive response inhale methacholine ( &lt; = 8mg/ml ) Positive response incremental inhale allergen challenge house dust mite allergen grass pollen allergen Available complete study measurement Women consider inclusion : Not pregnant , confirmed pregnancy test , nursing Of nonchild bear potential ( i.e . physiologically incapable become pregnant , include female premenarchial postmenopausal , document proof hysterectomy tubal ligation , meet clinical criterion menopause amenorrhoeic 1 year prior screen visit ) Of childbearing potential use highly effective method contraception entire study ( vasectomised partner , sexual abstinence lifestyle female complete abstinence intercourse two week prior study least 72 hour end study , implant , injectables , combine oral contraceptive , hormonal IUDs ) History upper low respiratory tract infection four week prior inform consent visit Past present disease , judge investigator , may affect outcome study . These disease include , limited , cardiovascular disease , malignancy , hepatic disease , renal disease , hematological disease , neurological disease , psychiatric disease , endocrine disease , infectious disease , inflammatory disease , pulmonary disease ( include confine chronic bronchitis , emphysema , tuberculosis , bronchiectasis cystic fibrosis ) . Clinically significant pathological finding safety laboratory test Regular intake medication short act inhaled beta agonist , paracetamol pain relief , birth control medication , hormonal replacement therapy , dietary vitamin supplement Specific Immunotherapy ( SIT ) within two year prior study Use antiinflammatory medication include systemic inhaled corticosteroid within last four week Any history lifethreatening asthma , define asthma episode require intubation and/or associate hypercapnea , respiratory arrest hypoxic seizure . Suspected hypersensitivity ingredient medication line bronchoscopy ( bronchodilator , sedatives local anesthetic ) Conditions factor , would make subject unlikely able undergo bronchoscopy incremental allergen challenge History drug alcohol abuse Suspected inability understand protocol requirement , instruction studyrelated restriction , nature , scope , possible consequence study . Participation clinical trial 30 day prior enrolment Segmental allergen challenge 3 month prior treatment Risk noncompliance study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Asthma GINA 1</keyword>
	<keyword>Mild intermittant asthma</keyword>
</DOC>